Galmed Pharmaceuticals Ltd (GLMD) Stock Price, Quote, News & History

GLMDNASDAQ
$0.6110
-0.0154-2.46%
At close: May 8, 5:00 PM EST
$0.6167
0.00570.93%
After Hours: 7:31 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.32M
Investing Cash Flow (TTM)
-3.38M
Financing Cash Flow (TTM)
9.03M
Free Cash Flow (TTM)
-6.32M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-664.00K

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$14.02M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.26
Earnings Yield % (TTM)
-381.51%
Earnings Yield % (FWD)
-249.02%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.39

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$3.99M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.63
Close
$0.61
Volume / Avg.
109.77K / 2.99M
Day Range
$0.61 - $0.66
52 Wk Range
0.41 - 2.34
Market Cap
$4.06M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
7.71%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Galmed Pharmaceuticals (GLMD) stock?

A

You can purchase shares of Galmed Pharmaceuticals (NASDAQ:GLMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Galmed Pharmaceuticals (GLMD) competitors?

Q

What is the forecast, or price target, for Galmed Pharmaceuticals (GLMD) stock?

A

Galmed Pharmaceuticals has a consensus price target of $4.00.

Q

What is the current price for Galmed Pharmaceuticals (GLMD)?

A

The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $0.6167 last updated May 8, 2026 at 7:31 PM EDT.

Q

Does Galmed Pharmaceuticals (GLMD) pay a dividend?

A

There are no upcoming dividends for Galmed Pharmaceuticals.

Q

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

A

Galmed Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Galmed Pharmaceuticals (GLMD) going to split?

A

There is no upcoming split for Galmed Pharmaceuticals.

Q

What sector and industry does Galmed Pharmaceuticals (GLMD) operate in?

A

Galmed Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.